Your browser doesn't support javascript.
loading
Multifunctional PLA/Gelatin Bionanocomposites for Tailored Drug Delivery Systems.
Moya-Lopez, Carmen; Juan, Alberto; Donizeti, Murillo; Valcarcel, Jesus; Vazquez, José A; Solano, Eduardo; Chapron, David; Bourson, Patrice; Bravo, Ivan; Alonso-Moreno, Carlos; Clemente-Casares, Pilar; Gracia-Fernández, Carlos; Longo, Alessandro; Salloum-Abou-Jaoude, Georges; Ocaña, Alberto; Piñeiro, Manuel M; Hermida-Merino, Carolina; Hermida-Merino, Daniel.
Afiliación
  • Moya-Lopez C; Laboratoire Matériaux Optiques Photonique et Systèmes (LMOPS), Centrale Supélec, Université de Lorraine, 57000 Metz, France.
  • Juan A; Centro Regional de Investigaciones Biomédicas, Unidad NanoCRIB, 02008 Albacete, Spain.
  • Donizeti M; Laboratoire Matériaux Optiques Photonique et Systèmes (LMOPS), Centrale Supélec, Université de Lorraine, 57000 Metz, France.
  • Valcarcel J; Group of Recycling and Valorization of Waste Materials (REVAL), Marine Research Institute (IIM-CSIC), 36208 Vigo, Spain.
  • Vazquez JA; Group of Recycling and Valorization of Waste Materials (REVAL), Marine Research Institute (IIM-CSIC), 36208 Vigo, Spain.
  • Solano E; NCD-SWEET Beamline, ALBA Synchrotron Light Source, 08290 Cerdanyola del Vallès, Spain.
  • Chapron D; Laboratoire Matériaux Optiques Photonique et Systèmes (LMOPS), Centrale Supélec, Université de Lorraine, 57000 Metz, France.
  • Bourson P; Laboratoire Matériaux Optiques Photonique et Systèmes (LMOPS), Centrale Supélec, Université de Lorraine, 57000 Metz, France.
  • Bravo I; Centro Regional de Investigaciones Biomédicas, Unidad NanoCRIB, 02008 Albacete, Spain.
  • Alonso-Moreno C; Centro Regional de Investigaciones Biomédicas, Unidad NanoCRIB, 02008 Albacete, Spain.
  • Clemente-Casares P; Facultad de Farmacia de Albacete, Universidad de Castilla-La Mancha, 02008 Albacete, Spain.
  • Gracia-Fernández C; Facultad de Farmacia de Albacete, Universidad de Castilla-La Mancha, 02008 Albacete, Spain.
  • Longo A; Unidad de Medicina Molecular, Centro Regional de Investigaciones Biomédicas, 02008 Albacete, Spain.
  • Salloum-Abou-Jaoude G; TA Instruments Waters Chromatography, Tres Cantos, 28760 Madrid, Spain.
  • Ocaña A; ID20, ESRF, 71 Avenue des Martyrs, 38000 Grenoble, France.
  • Piñeiro MM; Istituto per lo Studio dei Materiali Nanostrutturati (ISMN)-CNR, UOS Palermo, Via Ugo La Malfa, 153, 90146 Palermo, Italy.
  • Hermida-Merino C; Constellium C-TEC Technology Center, Parc Economique Centr'alp, 725 Rue Aristide Bergès CS10027, 38341 Voreppe, France.
  • Hermida-Merino D; Experimental Therapeutics Unit, Hospital Clínico San Carlos, IdISSC and CIBERONC, 28040 Madrid, Spain.
Pharmaceutics ; 14(6)2022 May 27.
Article en En | PubMed-not-MEDLINE | ID: mdl-35745711
A series of bionanocomposites composed of shark gelatin hydrogels and PLA nanoparticles featuring different nanostructures were designed to generate multifunctional drug delivery systems with tailored release rates required for personalized treatment approaches. The global conception of the systems was considered from the desired customization of the drug release while featuring the viscoelastic properties needed for their ease of storage and posterior local administration as well as their biocompatibility and cell growth capability for the successful administration at the biomolecular level. The hydrogel matrix offers the support to develop a direct thermal method to convert the typical kinetic trapped nanostructures afforded by the formulation method whilst avoiding the detrimental nanoparticle agglomeration that diminishes their therapeutic effect. The nanoparticles generated were successfully formulated with two different antitumoral compounds (doxorubicin and dasatinib) possessing different structures to prove the loading versatility of the drug delivery system. The bionanocomposites were characterized by several techniques (SEM, DLS, RAMAN, DSC, SAXS/WAXS and rheology) as well as their reversible sol-gel transition upon thermal treatment that occurs during the drug delivery system preparation and the thermal annealing step. In addition, the local applicability of the drug delivery system was assessed by the so-called "syringe test" to validate both the storage capability and its flow properties at simulated physiological conditions. Finally, the drug release profiles of the doxorubicin from both the PLA nanoparticles or the bionanocomposites were analyzed and correlated to the nanostructure of the drug delivery system.
Palabras clave

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Pharmaceutics Año: 2022 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Pharmaceutics Año: 2022 Tipo del documento: Article País de afiliación: Francia